Literature DB >> 5543727

Opsonic activity of agammaglobulinemic human sera.

R C Williams, P G Quie.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5543727

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


× No keyword cloud information.
  21 in total

1.  Pneumococcal type-associated variability in alternate complement pathway activation.

Authors:  D P Fine
Journal:  Infect Immun       Date:  1975-10       Impact factor: 3.441

2.  Serum factors capable of opsonizing Shigella for phagocytosis by polymorphonuclear neutrophils.

Authors:  W P Reed
Journal:  Immunology       Date:  1975-06       Impact factor: 7.397

3.  Opsonic requirements for phagocytosis of Streptococcus pneumoniae types VI, XVIII, XXIII, and XXV.

Authors:  G S Giebink; J Verhoef; P K Peterson; P G Quie
Journal:  Infect Immun       Date:  1977-11       Impact factor: 3.441

4.  Opsonic activity in human serum chelated with ethylene glycoltetra-acetic acid.

Authors:  A Forsgren; P G Quie
Journal:  Immunology       Date:  1974-06       Impact factor: 7.397

5.  Opsonic requirements for staphylococcal phagocytosis. Heterogeneity among strains.

Authors:  J Verhoef; P Peterson; Y Kim; L D Sabath; P G Quie
Journal:  Immunology       Date:  1977-08       Impact factor: 7.397

6.  Serum factors responsible for killing of Shigella.

Authors:  W P Reed; E L Albright
Journal:  Immunology       Date:  1974-01       Impact factor: 7.397

7.  Human polymorphonuclear leucocyte receptors for staphylococcal opsonins.

Authors:  J Verhoef; P K Peterson; P G Quie
Journal:  Immunology       Date:  1977-08       Impact factor: 7.397

Review 8.  Phagocytosis. Clinical disorders of recognition and ingestion.

Authors:  T P Stossel
Journal:  Am J Pathol       Date:  1977-09       Impact factor: 4.307

9.  Contribution of immunoglobulins M and G, complement, and properdin to the intracellular killing of Escherichia coli by polymorphonuclear leukocytes.

Authors:  J Menzel; H Jungfer; D Gemsa
Journal:  Infect Immun       Date:  1978-02       Impact factor: 3.441

10.  Opsonic defect in patients with cystic fibrosis of the pancreas.

Authors:  W D Biggar; B Holmes; R A Good
Journal:  Proc Natl Acad Sci U S A       Date:  1971-08       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.